Effects of the renal medullary pH and ionic environment on vasopressin binding and signaling

Kidney International

Volumn 74, Issue 12, 2008, Pages 1557-1567

  Zalyapin, Elena A ^a   Bouley, Richard ^a   Hasler, Udo ^a   Vilardaga, Jean Pierre ^a   Lin, Herbert Y ^a   Brown, Dennis ^a   Ausiello, Dennis A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

G protein coupled receptor signaling; Hypertonicity; Vasopressin

Indexed keywords

CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GREEN FLUORESCENT PROTEIN; OXYTOCIN; PARATHYROID HORMONE RECEPTOR; VASOPRESSIN; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HORMONE BINDING; IONIC STRENGTH; KIDNEY MEDULLA; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; ENDOCYTOSIS; HYDROGEN-ION CONCENTRATION; IONS; KIDNEY MEDULLA; OSMOLAR CONCENTRATION; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION; SWINE; VASOPRESSINS;

EID: 57049112626     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.412     Document Type: Article

References (78)

1. Birnbaumer M, Seibold A, Gilbert S et al. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357: 333-335.
2. Lolait SJ, O'Carroll AM, McBride OW et al. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 1992; 357: 336-339.
3. Morel A, O'Carroll AM, Brownstein MJ et al. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 1992; 356: 523-526.
4. Sugimoto T, Saito M, Mochizuki S et al. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 1994; 269: 27088-27092.
5. Calo G, Rizzi A, Traina L et al. Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery. Life Sci 1997; 60: PL63-PL68.
6. Jovanovic A, Grbovic L, Zikic I et al. Characterization of arginine vasopressin actions in human uterine artery: lack of role of the vascular endothelium. Br J Pharmacol 1995; 115: 1295-1301.
7. Loup F, Tribollet E, Dubois-Dauphin M et al. Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study. Brain Res 1991; 555: 220-232.
8. Saito M, Sugimoto T, Tahara A et al. Molecular cloning and characterization of rat V1b vasopressin receptor: evidence for its expression in extra-pituitary tissues. Biochem Biophys Res Commun 1995; 212: 751-757.
9. 3H]-SR 49059. Kidney Int 1996; 50: 499-505.
10. Tahara A, Tsukada J, Tomura Y et al. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. Br J Pharmacol 2000; 129: 131-139.
11. Tahri-Joutei A, Fillion C, Bedin M et al. Local control of Leydig cell arginine vasopressin receptor by naloxone. Mol Cell Endocrinol 1991; 79: R21-R24.
12. Thibonnier M, Coles P, Thibonnier A et al. The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists. Annu Rev Pharmacol Toxicol 2001; 41: 175-202.
13. Ventura MA, Rene P, de Keyzer Y et al. Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor. J Mol Endocrinol 1999; 22: 251-260.
14. Johnston CA, Siderovski DP. Receptor-mediated activation of heterotrimeric G-proteins: current structural insights. Mol Pharmacol 2007; 72: 219-230.
15. Thibonnier M. Genetics of vasopressin receptors. Curr Hypertens Rep 2004; 6: 21-26.
16. Digby GJ, Lober RM, Sethi PR et al. Some G protein heterotrimers physically dissociate in living cells. Proc Natl Acad Sci USA 2006; 103: 17789-17794.
17. Kamenetsky M, Middelhaufe S, Bank EM et al. Molecular details of cAMP generation in mammalian cells: a tale of two systems. J Mol Biol 2006; 362: 623-639.
18. Deen PM, Verdijk MA, Knoers NV et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994; 264: 92-95.
19. Nielsen S, Frøkiaer J, Marples D et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002; 82: 205-244.
20. Sabolic I, Katsura T, Verbavatz JM et al. The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats. J Membr Biol 1995; 143: 165-175.
21. Sasaki S, Kuwahara M, Yamashita Y et al. Structure and function of AQP2. Nephrol Dial Transplant 2000; 15(Suppl 6): 21-22.
22. Bouley R, Sun TX, Chenard M et al. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells. Am J Physiol Cell Physiol 2003; 285: C750-C762.
23. Yi X, Bouley R, Lin HY et al. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R. Am J Physiol Renal Physiol 2007; 292: F1303-F1313.
24. Bouley R, Lin HY, Raychowdhury MK et al. Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway. Am J Physiol Cell Physiol 2005; 288: C1390-C1401.
25. Robben JH, Knoers NV, Deen PM. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 2004; 15: 5693-5699.
26. Besseghir K, Trimble ME, Stoner L. Action of ADH on isolated medullary thick ascending limb of the Brattleboro rat. Am J Physiol 1986; 251: F271-F277.
27. Firsov D, Mandon B, Morel A et al. Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor. Pflugers Arch 1994; 429: 79-89.
28. Nonoguchi H, Owada A, Kobayashi N et al. Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest 1995; 96: 1768-1778.
29. Park F, Mattson DL, Skelton MM et al. Localization of the vasopressin V1a and V2 receptors within the renal cortical and medullary circulation. Am J Physiol 1997; 273: R243-R251.
30. Schlatter E, Greger R. cAMP increases the basolateral Cl-conductance in the isolated perfused medullary thick ascending limb of Henle's loop of the mouse. Pflugers Arch 1985; 405: 367-376.
31. Terada Y, Tomita K, Nonoguchi H et al. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest 1993; 92: 2339-2345.
32. Edwards RM, Jackson BA, Dousa TP. ADH-sensitive cAMP system in papillary collecting duct: effect of osmolality and PGE2. Am J Physiol 1981; 240: F311-F318.
33. Kersting U, Dantzler DW, Oberleithner H et al. Evidence for an acid pH in rat renal inner medulla: paired measurements with liquid ion-exchange microelectrodes on collecting ducts and vasa recta. Pflugers Arch 1994; 426: 354-356.
34. Good DW, Knepper MA. Ammonia transport in the mammalian kidney. Am J Physiol 1985; 248: F459-F471.
35. Hamm LL. Renal acidification in Kidney (vol 1), Brenner BM, Levine SA (eds.), Saunders: Philadelphia, 2004, pp 497-534.
36. Cohen DM. Signalling and gene regulation by urea and NaCl in the renal medulla. Clin Exp Pharmacol Physiol 1999; 26: 69-73.
37. Jamison RL, Robertson CR. Editorial review. Recent formulations of the urinary concentrating mechanism: a status report. Kidney Int 1979; 16: 537-545.
38. Knepper MA, Gamba G. Urine Concentration and Dilution in Kidney (vol 1). Brenner BM, Levine SA (eds.), Saunders: Philadelphia, 2004, pp 599-636.
39. Skorecki KL, Conte JM, Ausiello DA. Effects of hypertonicity on cAMP production in cultured renal epithelial cells (LLC-PK1). Miner Electrolyte Metab 1987; 13: 165-172.
40. Innamorati G, Le Gouill C, Balamotis M et al. The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors. J Biol Chem 2001; 276: 13096-13103.
41. Mori T, Cowley AW. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 2003; 42: 588-593.
42. Zhang Z, Rhinehart K, Kwon W et al. ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species. Am J Physiol Heart Circ Physiol 2004; 287: H773-H781.
43. Silbernagl S, Volker K, Dantzler WH. Compartmentation of amino acids in the rat kidney. Am J Physiol 1996; 270: F154-F163.
44. Bagnasco S, Balaban R, Fales HM et al. Predominant osmotically active organic solutes in rat and rabbit renal medullas. J Biol Chem 1986; 261: 5872-5877.
45. Bagnasco SM, Uchida S, Balaban RS et al. Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl. Proc Natl Acad Sci USA 1987; 84: 1718-1720.
46. Yamauchi A, Sugiura T, Kitamura H et al. Effects of partial nephrectomy on the expression of osmolyte transporters. Kidney Int 1997; 51: 1847-1854.
47. Jans DA, Hemmings BA. cAMP-dependent protein kinase activation affects vasopressin V2-receptor number and internalization in LLC-PK1 renal epithelial cells. FEBS Lett 1991; 281: 267-271.
48. Demaurex N. pH Homeostasis of cellular organelles. News Physiol Sci 2002; 17: 1-5.
49. Murphy RF, Powers S, Cantor CR. Endosome pH measured in single cells by dual fluorescence flow cytometry: rapid acidification of insulin to pH 6. J Cell Biol 1984; 98: 1757-1762.
50. Edwards BR, LaRochelle FT. Antidiuretic effect of endogenous oxytocin in dehydrated Brattleboro homozygous rats. Am J Physiol 1984; 247: F453-F465.
51. Lencer WI, Brown D, Ausiello DA et al. Endocytosis of water channels in rat kidney: cell specificity and correlation with in vivo antidiuresis. Am J Physiol 1990; 259: C920-C932.
52. Li C, Wang W, Summer SN et al. Molecular mechanisms of antidiuretic effect of oxytocin. J Am Soc Nephrol 2008; 19: 225-232.
53. Conrad KP, Gellai M, North WG et al. Influence of oxytocin on renal hemodynamics and electrolyte and water excretion. Am J Physiol 1986; 251: F290-F296.
54. Potter RR. Water retention due to oxytocin. Obstet Gynecol 1964; 23: 699-702.
55. Schrier RW. Vasopressin and aquaporin 2 in clinical disorders of water homeostasis. Semin Nephrol 2008; 28: 289-296.
56. Burgess WJ, Balment RJ, Beck JS. Effects of luminal vasopressin on intracellular calcium in microperfused rat medullary thick ascending limb. Ren Physiol Biochem 1994; 17: 1-9.
57. Ikeda M, Yoshitomi K, Imai M et al. Cell Ca2+ response to luminal vasopressin in cortical collecting tubule principal cells. Kidney Int 1994; 45: 811-816.
58. Musabayane CT, Forsling ML, Balment RJ. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors. Ren Fail 1997; 19: 23-32.
59. Maric C, Casley D, Harris P et al. Angiotensin II binding to renomedullary interstitial cells is regulated by osmolality. J Am Soc Nephrol 2001; 12: 450-455.
60. Klingler C, Ancellin N, Barrault MB et al. Potentiation of receptor-mediated cAMP production: role in the cross-talk between vasopressin V1a and V2 receptor transduction pathways. Biochem J 1998; 330(Part 2): 1023-1028.
61. Laycock JF, Hanoune J. From vasopressin receptor to water channel: intracellular traffic, constraint and by-pass. J Endocrinol 1998; 159: 361-372.
62. Phillips PA, Grant SL, Davidson AF et al. Epidermal growth factor antagonizes vasopressin in vivo and in vitro. Kidney Int 1994; 45: 1028-1036.
63. Roy C, Ausiello DA. Regulation of vasopressin binding to intact cells. Ann NY Acad Sci 1981; 372: 92-105.
64. Roy C, Hall D, Karish M et al. Relationship of (8-lysine) vasopressin receptor transition to receptor functional properties in a pig kidney cell line (LLC-PK1). J Biol Chem 1981; 256: 3423-3427.
65. Baudouin-Legros M, Badou A, Paulais M et al. Hypertonic NaCl enhances adenosine release and hormonal cAMP production in mouse thick ascending limb. Am J Physiol 1995; 269: F103-F109.
66. DeRubertis FR, Craven PA. Effects of osmolality and oxygen availability on soluble cyclic AMP-dependent protein kinase activity of rat renal inner medulla. J Clin Invest 1978; 62: 1210-1221.
67. Riccardi D, Lee WS, Lee K et al. Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996; 271: F951-F956.
68. Torikai S, Wang MS, Klein KL et al. Adenylate cyclase and cell cyclic AMP of rat cortical thick ascending limb of Henle. Kidney Int 1981; 20: 649-654.
69. Baudouin-Legros M, Asdram L, Tondelier D et al. Extracellular urea concentration modulates cAMP production in the mouse MTAL. Kidney Int 1996; 50: 26-33.
70. Dousa TP. Effect of renal medullary solutes on vasopressin-sensitive adenyl cyclase. Am J Physiol 1972; 222: 657-662.
71. Santos BC, Chevaile A, Hebert MJ et al. A combination of NaCl and urea enhances survival of IMCD cells to hyperosmolality. Am J Physiol 1998; 274: F1167-F1173.
72. Zhang Z, Tian W, Cohen DM. Urea protects from the proapoptotic effect of NaCl in renal medullary cells. Am J Physiol Renal Physiol 2000; 279: F345-F352.
73. Lee YJ, Song IK, Jang KJ et al. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol 2007; 292: F340-F350.
74. Wong NL, Tsui JK. Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat. Metabolism 2003; 52: 290-295.
75. Hasler U, Jeon US, Kim JA et al. Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. J Am Soc Nephrol 2006; 17: 1521-1531.
76. Hasler U, Nielsen S, Feraille E et al. Posttranscriptional control of aquaporin-2 abundance by vasopressin in renal collecting duct principal cells. Am J Physiol Renal Physiol 2006; 290: F177-F187.
77. Kasono K, Saito T, Saito T et al. Hypertonicity regulates the aquaporin-2 promoter independently of arginine vasopressin. Nephrol Dial Transplant 2005; 20: 509-515.
78. Shimizu N, Dean T, Tsang JC et al. Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptor. J Biol Chem 2005; 280: 1797-1807.